BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, January 26, 2026
Home
»
Newsletters
» BioWorld
BioWorld
April 5, 2010
View Archived Issues
Sequencing Speeds Up, But Drug Discovery Still a Slog
Read More
Biotech's Future: BioWorld Gives You 2020 Vision in 2010!
Read More
Appointments And Advancements
Read More
Vital Signs
Read More
Other News To Note
Read More
Financings Roundup
Read More
Clinic Roundup
Read More
Bench Press
Read More
Salix Liver-Failure Win Puts Spotlight on Xifaxan in IBS
Salix Pharmaceuticals Inc.'s path forward should become clear shortly with the approved antibiotic Xifaxan in its third potential, and much-coveted, indication: irritable bowel syndrome. (BioWorld Today)
Read More
New NYU Stem Cell Lines Boost NIH Registry to 51
Read More
